Overview

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
A study to Assess the Pharmacokinetics of Rosuvastatin and Simvastatin when administered alone or in combination with Fostamatinib.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium
Simvastatin